Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 1999

View Archived Issues

U.S. DOD funds study of HupA as neuroprotective agent

High-dose tirilazad mesilate assessed in women with aneurysmal subarachnoid hemorrhage

Celgene reports potent, specific immune responses for thalidomide analogues

Cortecs provides research and development update

Oxford BioMedica and Modex Therapeutiques to develop diabetes therapy

Columbia Laboratories finalizes Crinone license transfer

Phase I trials evaluating J695 now under way

Nastech completes phase III testing of intranasal scopolamine

Perstorp subsidiary merges with Endogen

Bristol-Myers Squibb extends antiinfective collaboration with Cubist Pharmaceuticals

Solvay completes financing for Unimed tender offer, extends tender offer

Disappointing phase II trial results for Ergoset in the treatment of obesity

Structurally novel antitumor and immunosuppressive compounds from Klinge

U.S. patent covers Immucon's novel male contraceptive vaccine technology

Novel gabapentin analogues with anticonvulsant and/or analgesic effects

Neurocrine Biosciences reacquires rights to novel MS treatment

Cytokine suppressors for immune disorders developed at SS Pharm.

Indena presents novel paclitaxel derivatives with excellent antitumor activity

New MMP inhibitors, their preparation and use described by Pfizer scientists

Yoshitomi describes potent, selective tryptase inhibitors

Promising new atypical antipsychotic agent with positive effects on cognition: RGH-1756

WHO develops pyronaridine, an orally active agent for treating chloroquine-resistant malaria

Collaborative antipsychotic R&D yields interesting candidates for development

Inhibitors of protein geranylgeranylation developed at Baldacci as antitumor agents

Roche to develop and market Trimeris's HIV fusion inhibitors

More on PEDF: protein also has ophthalmic indications

Nonsteroidal Rx for atopic dermatitis enters late-stage clinical trials in U.S.

SomatoKine given orphan drug status as treatment of severe burns

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...